Veru Inc. (NASDAQ: VERU) reported its financial results for the second quarter ended March 31, 2021, on Wednesday before the market opens.
The company had net revenue of $13.3 million with an increase of 34%.
Veru Inc suffered a net loss of $2.8 million or $0.04 loss per share compared to the loss of $0.8 million or $0.01 loss per share of the same quarter in the previous year.
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated